EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Restricted expression of latency-associated viral genes and production of viral IL-10 in Epstein-Barr virus-related NK/T-cell lymphomas



Restricted expression of latency-associated viral genes and production of viral IL-10 in Epstein-Barr virus-related NK/T-cell lymphomas



Journal of Dermatological Science 23(3): 198, August




(PDF emailed within 1 workday: $29.90)

Accession: 035661029

Download citation: RISBibTeXText



Related references

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. British Journal of Cancer 84(7): 920-925, 2001

Molecular size variation of epstein barr virus induced nuclear antigen is determined by the epstein barr viral genome studies on sublines of epstein barr virus negative lymphomas converted with different epstein barr virus substrains and on somatic hybrids. Intervirology 22(2): 85-96, 1984

T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. New England Journal of Medicine 318(12): 733-741, 1988

Expression of two related viral early genes in Epstein-Barr virus-associated tumors. Journal of Virology 74(6): 2793-2803, 2000

Presence of Epstein-Barr virus viral interleukin-10 in the serum of patients with non-human-immunodeficiency-virus-related diffuse large-cell non-Hodgkin's lymphomas. Blood 86(12): 4702-4704, 1995

Expression of Epstein-Barr virus genes in different cell types after microinjection of viral DNA. Proceedings of the National Academy of Sciences of the United States of America 77(1): 433-436, 1980

Switching viral latency to viral lysis: a novel therapeutic approach for Epstein-Barr virus-associated neoplasia. Cancer Research 56(5): 969-972, 1996

Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency. Advances in Cancer Research 58: 1-26, 1992

Epstein-Barr virus-latent gene expression and tumor cell phenotype in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Correlation of lymphoma phenotype with three distinct patterns of viral latency. American Journal of Pathology 143(4): 1072-1085, 1993

Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription. Aids 21(16): 2141-2149, 2007

Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma. Biotechnology and Applied Biochemistry 47(Pt 1): 59-69, 2006

Expression of VCA (viral capsid antigen) and EBNAI (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma. Biotechnology and Applied Biochemistry 47(Part 1): 59-69, 2007

Latency vs lytic cycle of Epstein-Barr virus: regulation of a viral gene expression is the clue. Pathologie-Biologie 52(2): 63-65, 2004

Viral genotypes and p53 expression in Epstein-Barr virus-associated primary malignant lymphomas of the intestines. Human Pathology 30(10): 1146-1152, 1999

A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. American Journal of Pathology 140(6): 1315-1325, 1992